Projects per year
Organization profile
Organization profile
The mission of the Center for Translational Medicine is to support the development of novel, investigator-initiated treatment strategies in order to facilitate the implementation of new therapies for patients and achieve new breakthroughs in medicine at the University. The Center has a well-equipped lab and a full-time staff and provides the infrastructure, expertise and resources necessary to translate innovative drugs, biological reagents and devices into Phase 1 clinical trials. Working with innovators from across the University, the Center designs and conducts the preclinical studies necessary for IND/IDE development and supports Phase I clinical trial design and implementation, including manufacture of clinical product.
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 9 Industry, Innovation, and Infrastructure
Fingerprint
Dive into the research topics where Center for Translational Medicine is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Lia G Coicou
- Center for Translational Medicine - Research Professional 4
- Office of Academic Clinical Affairs
Person: Researchers
-
Brenda Koniar
- Center for Translational Medicine - Research Professional 2
- Office of Academic Clinical Affairs
Person: Research Support
-
Beverly Norris
- Center for Translational Medicine - Research Professional 5
- Office of Academic Clinical Affairs
Person: Research Support
-
Nebulized T3 Therapy for Acute Heart Failure & Lung Injury
Ingbar, D. H. (PI), Schumacher, R. J. (CoI) & Elliott, A. (Co-Principal Investigator)
DR. RALPH & MARIAN FALK MED RES TRUST
11/30/25 → 11/29/28
Project: Research project
-
Treating drug-resistant infections of burn wounds with an optimized antimicrobial peptide
Gorr, S.-U. (PI) & Schumacher, R. J. (CoI)
GAVIA BIO, LLC, NATIONAL INSTITUTES OF HEALTH (NIH)
9/5/25 → 8/31/26
Project: Research project
-
Preclinical Testing of Therapeutic Candidates
Schumacher, R. J. (PI)
1/1/24 → 12/31/29
Project: Research project
-
Preclinical quality, safety, and efficacy of a CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophies
Azzag, K., Magli, A., Kiley, J., Sumstad, D., Kadidlo, D., Crist, S. B., Norris, B., Ahlquist, A., Hocum Stone, L. L., Everett, J., Shappa Faustich, J., Seelig, D., Rangarajan, P., Kim, H., Flory, C., Bushman, F., Ramachandran, S., Kang, P. B., Schumacher, R. J. & Wagner, J. E. & 4 others, , Oct 1 2025, In: Molecular Therapy. 33, 10, p. 5099-5117 19 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Link opens in a new tab Scopus citations -
Domain-selective and sex-dependent regulation of learning and memory in mice by GIRK channel activity in CA1 pyramidal neurons of the dorsal hippocampus
Luo, H., Frederick, M., de Velasco, E. M. F., Oltmanns, J. O., Wright, C. & Wickman, K., 2024, In: Learning and Memory. 31, 9, a054022.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo
Naumann, J. A., Argyris, P. P., Carpenter, M. A., Gupta, H. B., Chen, Y., Temiz, N. A., Zhou, Y., Durfee, C., Proehl, J., Koniar, B. L., Conticello, S. G., Largaespada, D. A., Brown, W. L., Aihara, H., Vogel, R. I. & Harris, R. S., Jun 2023, In: International journal of molecular sciences. 24, 11, 9305.Research output: Contribution to journal › Article › peer-review
Open Access15 Link opens in a new tab Scopus citations